Funding

Celea Therapeutics

United States · Biotech · Healthtech · Enterprise software

Develops treatments for serious respiratory diseases

Visit celeatx.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Growth$180MLeaps by Bayer — Role not disclosedPureTech Health — Role not disclosedRA Capital Management — Role not disclosed

Investors

Leaps by BayerGrowthPureTech HealthGrowthRA Capital ManagementGrowth

Coverage

Jul 2, 2026Celea Therapeutics · Growth

Similar companies

Estuary BiotherapeuticsEstuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.$93M · Series A
Abby CareAbby Care trains and supports eligible family members as paid caregivers, combining nurse-led care management with software that documents care at home.$82M · Series C
HoloHolo helps small businesses plan marketing campaigns, create content and publish it across connected channels.€5M · Seed
Sourcesceleatx.com ↗